Departmental seminar by Dr Afshin Safavi

Biography

Dr. Afshin Safavi is a founder, consultant, board member, entrepreneur, and investor in biotechnology, pharmaceutical, animal health, technology, and real-estate sectors with multi-billion-dollar turnovers in biological products and is responsible for multiple drug products in the market today. He has founded Colorado Health and Tech Centers (CHTC), Novel351k, and BioAgilytix Labs, one of the most successful multi-billion-dollar Contract Research Organizations known internationally. His last four consecutive exits delivered 7 to 200x returns in 5 years or less. He has extensive experience establishing and leading teams in pharmaceutical and manufacturing companies.

Before founding Colorado Health and Tech Centers (CHTC), NOVEL351K, and BioAgilytix Labs, he worked for various organizations, including AAIPharma, Bayer Biologicals, Talecris BioTherapeutics (Grifols), Nobex Corporation, GlaxoSmithKline, and IGEN International. Dr. Safavi obtained his B.S. in Biochemistry from UCLA and his Ph.D. in Biochemistry from the University of Kentucky Medical School. He completed a two-year postdoctoral assignment at the Emory University, Department of Pathology.